Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

This study has been terminated.
(Further evaluation of phase I dosing)
Sponsor:
Collaborator:
Progen Pharmaceuticals
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00585416
First received: December 21, 2007
Last updated: September 30, 2015
Last verified: April 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2009
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)